Terra Innovatum Global N.V. Receives Nasdaq Deficiency Notice for Late Filing of Annual Report

Date: April 16, 2026

Company: Terra Innovatum Global N.V. (NASDAQ: NKLR)

Key Points for Investors

• Nasdaq Deficiency Notice: Terra Innovatum Global N.V. (the “Company”) has received a deficiency notice from the Nasdaq Listing Qualifications Department. The notice was issued because the Company failed to timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2025, as required by Nasdaq Listing Rule 5250(c)(1) for continued listing on the Nasdaq Global Select Market.
• No Immediate Impact on Listing: The notice does not result in the immediate delisting or suspension of trading in the Company’s ordinary shares (par value €0.01 per share, trading symbol: NKLR) on the Nasdaq Global Select Market.
• Compliance Timeline: The Company has 60 calendar days (until June 15, 2026) to submit a plan to Nasdaq detailing how it intends to regain compliance with the filing requirement.
• Potential Extension: If the plan is accepted, Nasdaq may grant the Company up to 180 calendar days from the original due date of the Form 10-K (or until October 12, 2026, if extended under Rule 12b-25) to file the report and regain compliance.
• Company’s Intent: Terra Innovatum Global N.V. has stated its intention to regain compliance with Nasdaq’s listing rules as soon as practicable.
• Emerging Growth Company: The Company is classified as an emerging growth company and has not elected to use the extended transition period for new or revised financial accounting standards.

Important Considerations for Shareholders

• Potential Share Price Impact: Although the deficiency notice does not immediately affect trading, it is a material event that may be price sensitive. If the Company is unable to file the required Form 10-K within the specified period, or if Nasdaq does not accept the Company’s compliance plan, the Company’s shares may be subject to suspension or delisting from Nasdaq, which could have a significant negative impact on share value.
• Regulatory Risk: The delayed filing may raise concerns among investors regarding the Company’s financial reporting controls and overall transparency. This could influence market perception and increase share price volatility.
• Continued Trading Symbol and Exchange: The Company’s ordinary shares continue to trade under the symbol NKLR on the Nasdaq Stock Market.
• Next Steps: Investors should closely monitor future filings and Company announcements regarding the status of the Form 10-K and compliance with Nasdaq’s requirements.

Summary Table

Conclusion

The deficiency notice from Nasdaq is a significant development for Terra Innovatum Global N.V. shareholders. While there is no immediate risk of delisting, the situation requires close monitoring. Shareholders should pay attention to Company updates regarding the 2025 Form 10-K filing and Nasdaq’s response to the Company’s compliance plan. Any adverse developments could trigger a strong reaction in the Company’s share price.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should conduct their own due diligence or consult with a qualified financial advisor before making any investment decisions. The information provided herein is based on publicly available documents dated April 16, 2026 and may not reflect subsequent developments.